Quick Overview: A double feature presentation by Monica Gandhi MD, MPH, Professor of Medicine, Division of HIV, Infectious Diseases, and ... In this episode featuring faculty from the United States and Europe, Aadia I. Rana, MD, and Laurence Slama, MD, PhD, discuss ... UCSF HIV Grand Rounds Spring 2026 Seminar with Monica Gandhi, MD, MPH.

Long Acting Art For Viremic - Detailed Overview & Context

A double feature presentation by Monica Gandhi MD, MPH, Professor of Medicine, Division of HIV, Infectious Diseases, and ... In this episode featuring faculty from the United States and Europe, Aadia I. Rana, MD, and Laurence Slama, MD, PhD, discuss ... UCSF HIV Grand Rounds Spring 2026 Seminar with Monica Gandhi, MD, MPH. In this episode, Ian Frank, MD, discusses Dr. Monica Gandhi shares experience and data from UCSF with prescribing injectable, Speaker: Roy Gulick, MD, MPH, Weill Cornell Medicine, United Kingdom Presented at Plenary Session 3:

UCSF HIV Grand Rounds Winter 2025 Seminar with Monica Gandhi, MD, MPH based at Zuckerberg San Francisco General ... Lily Ostrer, MD (she/her) Infectious Disease Fellow, (3rd Year Med/Peds) Division of Infectious Diseases and Global Public Health ... Ian Frank, MD, discusses upcoming treatments for people with HIV. Carlos del Rio, Co-director, Emory Center for AIDS Research, discusses advances in Joseph Eron, MD, professor of medicine at the University of Carolina at Chapel Hill, discusses benefits of Presenter: Joseph J. Eron, Jr, MD Presented on January 21, 2020 To earn CME from on-demand webinars, visit ...

Dr. Brian Wood reviews recent data and recommendations on use of This talk by Brian Wood, MD includes the following topics: update on Joseph Eron, MD, professor of medicine at the University of Carolina at Chapel Hill, discusses when clinicians may expect to have ... Jason Schafer, PharmD, MPH, BCPS AQ-ID, Associate Professor at Thomas Jefferson University, discusses upcoming Dr. Shireesha Dhanireddy discusses logistical considerations and operationalizing prescription and administration of

Photo Gallery

"Long-acting ART for Viremic Populations" and "Updates on LATITUDE ..."
Considering Long-acting ART With Viremia and Past Adherence Challenges
Long-Acting ART in Practice: Lessons from Ward 86
Long-Acting ART: Cabotegravir Plus Rilpivirine
Webinar: LAI-ART - Questions for Implementing Long-acting Medications in HIV Treatment Programs
Long-Acting Cabotegravir / Rilpivirine for Individuals With Detectable Viral Loads
Positioning Long-acting ARV in LMIC - Roy Gulick, MD, MPH
Updates in Long-Acting ART and PrEP
Long-Acting Antiretroviral Therapy among People with Substance Use Disorders
Long-Acting ART, Islatravir, and Capsid Inhibitors
Long-Acting ART and the Cost of HIV Therapies
Long-Acting Injectable ART: Benefits & Misconceptions
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored